// App-Quantinova.ai

1544 : Influence of Thrombophilia on the Efficacy of Dabigatran Versus Warfarin for the Extended Treatment of Acute Venous Thromboembolism in RE-MEDY

Researchers

Presenter

  • Sam Schulman

Principal Investigators

  • Henry Eriksson

  • Samuel Z. Goldhaber

  • Ajay Kakkar

  • Clive Kearon

  • Sebastian M Schellong

  • Martin Feuring

  • Jeffrey Friedman

  • Joerg Kreuzer

Medical Centers

  • Cardiovascular Division, Brigham and Womens Hospital, Harvard Medical School, Boston, MA

  • Sahlgrenska University Hospital, Gothenburg, Sweden

  • Friedman Consulting, Portland, OR

  • Municipal Hospital Friedrichstadt, Dresden, Germany

  • McMaster University, Hamilton, ON, Canada

  • Thrombosis Research Institute and University College London, London, United Kingdom

Locations

  • Canada

  • Germany

  • United Kingdom

  • United States

  • Sweden

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • Pradax

  • Warfarin

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved